NASDAQ Equity Snapshot

ARTV Weekly Equity Report

Artiva Biotherapeutics, Inc. Common Stock

Interactive chart JSON snapshot
Latest Close 8.54 USD 12 Jun 2026
1W Return 24.7% latest completed week
4W Return -12.7% short-term follow-through
12W Return 60.5% quarterly tape
Trend Breadth 69.2% 36 of 52 weeks active
Volume Ratio 2.0x vs 13-week average
Company Brief

What the company does

Artiva Biotherapeutics, Inc. is a pioneering biotechnology firm focused on developing next-generation cell therapies specifically targeting cancer, leveraging its proprietary platform to enhance natural killer (NK) cell therapies. With a diverse pipeline aimed at various hematologic and solid tumors, Artiva demonstrates a strong commitment to innovation within the immuno-oncology sector. The company emphasizes scientific rigor and has established strategic collaborations, positioning it favorably to make significant strides in cancer treatment and improve patient outcomes as its promising therapeutic candidates advance through clinical trials.

Snapshot

What the weekly tape is saying

ARTV closed the latest completed week at 8.54 USD. The 4-week return is -12.7% and the 12-week return is 60.5%. Trend Signal is active, Market Dynamics is 0.02. Setup signature: Deep recovery attempt with a 64/100 composite read.

Trend Signal Active
Market Dynamics No fresh buy
Price vs Trend 38.9%
Volume 2.0x
Setup Cockpit

A compressed read of the whole setup

The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.

Composite setup radar

Scoreboard

Trend 83 Persistence of active Trend Signal over the last year and current streak.
Momentum 75 Blend of 4-week and 12-week follow-through.
Dynamics 43 Latest Market Dynamics and whether pressure has improved over four weeks.
Relative Strength 100 Relative leadership and short-term RS change.
Volume 85 Participation compared with the 13-week volume baseline.
Risk Control 0 Drawdown and recent weekly volatility pressure.

16-week signal tape

27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 2 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun
Weekly return bar Trend Signal dot Positive Market Dynamics dot
Price Action

Price, Trend Line, and Fair Value

Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.

52-week price path

Price Trend Line Fair Value

Price map

Trend Line
6.15 USD
Vs Trend Line
38.9%
Fair Value
6.26 USD
Vs Fair Value
36.5%
52W High
14.53 USD
52W Low
1.47 USD
Drawdown
-41.2%
Range Position
54.1%
Momentum

Returns and trend persistence

Return windows separate the latest week from short-term and medium-term follow-through.

Return windows

1W 24.7%
4W -12.7%
12W 60.5%
26W 158.8%
52W 331.3%

Trend read

Active Streak
36 weeks
52W Active Weeks
36
52W Active Breadth
69.2%
Sector Scope
US Healthcare
Sector Rank
20 of 1038
Sector Percentile
98.2%
Peer Context

Sector and industry pulse

Peer breadth helps separate a stock-specific move from a broader group rotation.

Market Dynamics

Pressure, Relative Strength, and expectation

Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.

Dynamics path

Market Dynamics Relative Strength

Signal state

Market Dynamics
0.02
4W MD Change
-98.6%
Relative Strength
53.23
4W RS Change
-42.1%
Expectation
Undecided
Probability
46.64%
Volume

Participation and confirmation

Volume tells us whether the latest weekly move is being confirmed by unusual participation.

52-week volume profile

Volume map

Latest Volume
4.6M
13W Average
2.3M
52W Average
4.6M
Vs 13W
2.0x
Vs 52W
1.0x
Risk Anatomy

Volatility, downside weeks, and return shape

A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.

26-week return distribution

Risk map

13W Volatility
27.4%
52W Volatility
25.1%
Upside Weeks
26
Downside Weeks
26
Downside Breadth
50.0%
Avg Gain / Loss
21.3% / -10.8%
Context

Classification, opportunities, risks, and watch points

Top-level read across company classification, constructive evidence, caution points, and the next things that matter.

Classification

Exchange
NASDAQ
Country
US
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Market Cap
385.3M

Opportunity signals

  • Trend Signal is active with a 36-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Market Dynamics is positive on the latest completed week.
  • Volume is elevated versus the 13-week average, confirming attention.

Risk signals

  • The share remains more than 20% below its 52-week high.

Watch next

  • Trend Line remains the key weekly regime level.
  • Market Dynamics is the pressure gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Weekly Tape

Recent completed weeks

The latest weekly rows behind the report snapshot.

Week Close Return Trend Fair Value MD RS Volume Signal
12 Jun 2026 8.54 USD 24.7% 6.15 USD 6.26 USD 0.02 53.23 4.6M On
5 Jun 2026 6.85 USD -13.6% 5.97 USD 6.23 USD 0.30 28.32 2.0M On
29 May 2026 7.93 USD 0.8% 5.86 USD 6.23 USD 0.83 43.96 1.6M On
22 May 2026 7.87 USD -19.5% 5.74 USD 6.21 USD 1.20 49.71 3.1M On
15 May 2026 9.78 USD -10.2% 5.65 USD 6.19 USD 1.53 91.89 2.8M On
8 May 2026 10.89 USD 0.8% 5.53 USD 6.15 USD 1.73 118.76 6.0M On
1 May 2026 10.80 USD 4.7% 5.26 USD 6.10 USD 1.74 136.03 1.1M On
24 Apr 2026 10.32 USD -17.8% 5.00 USD 6.05 USD 1.79 136.40 1.9M On
17 Apr 2026 12.55 USD 84.3% 4.75 USD 6.00 USD 1.52 203.28 3.4M On
10 Apr 2026 6.81 USD 1.0% 4.43 USD 5.93 USD 1.36 82.60 953.6K On
2 Apr 2026 6.74 USD 34.5% 4.29 USD 5.92 USD 1.38 92.90 745.8K On
27 Mar 2026 5.01 USD -5.8% 4.18 USD 5.91 USD 1.38 51.89 492.5K On
20 Mar 2026 5.32 USD -13.9% 4.12 USD 5.92 USD 1.63 57.19 662.1K On
13 Mar 2026 6.18 USD 7.7% 4.04 USD 5.93 USD 1.52 79.14 1.7M On